Filtered By:
Therapy: Stem Cell Therapy

This page shows you your search results in order of relevance. This is page number 14.

Order by Relevance | Date

Total 25607 results found since Jan 2013.

Bioengineered Scaffolds for Stem Cell Applications in Tissue Engineering and Regenerative Medicine.
Authors: Rahmati M, Pennisi CP, Mobasheri A, Mozafari M Abstract Stem cell-based therapies, harnessing the ability of stem cells to regenerate damaged or diseased tissues, are under wide-ranging consideration for regenerative medicine applications. However, limitations concerning poor cell persistence and engraftment upon cell transplantation still remain. During the recent years, several types of biomaterials have been investigated to control the fate of the transplanted stem cells, aiming to increase their therapeutic efficiency. In the present chapter we focus on the general properties of some of these biomateri...
Source: Advances in Experimental Medicine and Biology - May 18, 2018 Category: Research Tags: Adv Exp Med Biol Source Type: research

Regenerative Medicine Applications of Mesenchymal Stem Cells.
Authors: Hosseini S, Taghiyar L, Safari F, Baghaban Eslaminejad M Abstract A major research challenge is to develop therapeutics that assist with healing damaged tissues and organs because the human body has limited ability to restore the majority of these tissues and organs to their original state. Tissue engineering (TE) and regenerative medicine (RM) promises to offer efficient therapeutic biological strategies that use mesenchymal stem cells (MSCs). MSCs possess the capability for self-renewal, multilineage differentiation, and immunomodulatory properties that make them attractive for clinical applications. The...
Source: Advances in Experimental Medicine and Biology - May 18, 2018 Category: Research Tags: Adv Exp Med Biol Source Type: research

Between the Local and the Global: < i > Evaluating European regulation of stem cell regenerative medicine < /i > .
Between the Local and the Global: <i>Evaluating European regulation of stem cell regenerative medicine</i>. Perspect Biol Med. 2018;61(1):42-58 Authors: Hauskeller C Abstract Current European regulations hinder the compilation of the evidence that would be required to bring safe and effective autologous stem cell-based interventions (SCBIs) into standard clinical care. European agencies have expanded their regulations to cover all new SCBIs and research. They establish demanding conditions for cell retrieval, processing, and application. Drawing on empirical sociological findings from the ...
Source: Perspectives in Biology and Medicine - June 1, 2018 Category: Medical Ethics Authors: Hauskeller C Tags: Perspect Biol Med Source Type: research

Cloning and expansion of antigen-specific T cells using iPS cell technology: Possible use of regenerated T cells in personalized medicine
Publication date: July 2018Source: Personalized Medicine Universe, Volume 7Author(s): Hiroshi Kawamoto, Kyoko Masuda, Seiji NaganoAbstractRecent advances in adoptive immunotherapy using cytotoxic T lymphocytes (CTLs) have demonstrated that CTLs are effective in killing tumor cells in vivo for some tumor types. However, a critical issue that CTLs collected from patients are easily exhausted during expansion culture is yet to be addressed. Therefore, we have been developing a strategy that utilizes induced pluripotent stem cell (iPSC) technology, based on the idea that iPSCs produced from antigen-specific CTLs would regener...
Source: Personalized Medicine Universe - July 6, 2018 Category: Drugs & Pharmacology Source Type: research

The potential of adipose-derived stem cell subpopulations in regenerative medicine
Regenerative Medicine,Volume 13, Issue 4, Page 357-360, June 2018.
Source: Future Medicine: Regenerative Medicine - July 6, 2018 Category: Genetics & Stem Cells Authors: Richard JP Smith Adam J Reid Source Type: research

Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions 1 January –28 February 28 2018
Regenerative Medicine,Volume 13, Issue 4, Page 361-370, June 2018.
Source: Future Medicine: Regenerative Medicine - July 6, 2018 Category: Genetics & Stem Cells Authors: Dusko Ilic Source Type: research

Cloning and expansion of antigen-specific T cells using iPS cell technology: Possible use of regenerated T cells in personalized medicine
Publication date: July 2018Source: Personalized Medicine Universe, Volume 7Author(s): Hiroshi Kawamoto, Kyoko Masuda, Seiji NaganoAbstractRecent advances in adoptive immunotherapy using cytotoxic T lymphocytes (CTLs) have demonstrated that CTLs are effective in killing tumor cells in vivo for some tumor types. However, a critical issue that CTLs collected from patients are easily exhausted during expansion culture is yet to be addressed. Therefore, we have been developing a strategy that utilizes induced pluripotent stem cell (iPSC) technology, based on the idea that iPSCs produced from antigen-specific CTLs would regener...
Source: Personalized Medicine Universe - July 10, 2018 Category: Drugs & Pharmacology Source Type: research

Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions 01 –31 March 2018
Regenerative Medicine, Ahead of Print.
Source: Future Medicine: Regenerative Medicine - July 24, 2018 Category: Genetics & Stem Cells Authors: Dusko Ilic Source Type: research

Bridging stem cell research and medicine: a learning health system
Regenerative Medicine, Ahead of Print.
Source: Future Medicine: Regenerative Medicine - July 25, 2018 Category: Genetics & Stem Cells Authors: Seydina B Tour é Erika Kleiderman Bartha M Knoppers Source Type: research

Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions 1 April –31 May 2018
Regenerative Medicine, Ahead of Print.
Source: Future Medicine: Regenerative Medicine - September 24, 2018 Category: Genetics & Stem Cells Authors: Dusko Ilic Source Type: research

Stem cell biologist Sean Morrison elected to the National Academy of Medicine
(UT Southwestern Medical Center) UT Southwestern Professor Dr. Sean Morrison, Director of the Children's Medical Center Research Institute (CRI) at UT Southwestern, has been elected to the National Academy of Medicine (NAM), one of the highest honors in the fields of health and medicine.
Source: EurekAlert! - Medicine and Health - October 18, 2018 Category: International Medicine & Public Health Source Type: news

Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from non-academic institutions June 1 –June 30, 2018
Regenerative Medicine, Ahead of Print.
Source: Future Medicine: Regenerative Medicine - November 19, 2018 Category: Genetics & Stem Cells Authors: Dusko Ilic Source Type: research

Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from non-academic institutions 1 July –31 August 2018
Regenerative Medicine, Ahead of Print.
Source: Future Medicine: Regenerative Medicine - November 23, 2018 Category: Genetics & Stem Cells Authors: Dusko Ilic Source Type: research

Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions September 1 –30, 2018
Regenerative Medicine, Ahead of Print.
Source: Future Medicine: Regenerative Medicine - December 18, 2018 Category: Genetics & Stem Cells Authors: Dusko Ilic Source Type: research

Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions in October 2018
Regenerative Medicine, Ahead of Print.
Source: Future Medicine: Regenerative Medicine - January 8, 2019 Category: Genetics & Stem Cells Authors: Dusko Ilic Source Type: research